These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15296859)

  • 1. Multifaceted roles of cyclooxygenase-2 in lung cancer.
    Riedl K; Krysan K; Põld M; Dalwadi H; Heuze-Vourc'h N; Dohadwala M; Liu M; Cui X; Figlin R; Mao JT; Strieter R; Sharma S; Dubinett SM
    Drug Resist Updat; 2004 Jun; 7(3):169-84. PubMed ID: 15296859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
    Saha D; Pyo H; Choy H
    Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer.
    Liao Z; Milas L
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):543-60. PubMed ID: 15270659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 in lung cancer.
    Dubinett SM; Sharma S; Huang M; Dohadwala M; Pold M; Mao JT
    Prog Exp Tumor Res; 2003; 37():138-62. PubMed ID: 12795053
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclooxygenase as a target in lung cancer.
    Brown JR; DuBois RN
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4266s-4269s. PubMed ID: 15217972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why cyclooxygenase-2 inhibition plus chemotherapy?
    Sweeney CJ
    Am J Clin Oncol; 2003 Aug; 26(4):S122-5. PubMed ID: 12902869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy.
    Romano M; Claria J
    FASEB J; 2003 Nov; 17(14):1986-95. PubMed ID: 14597668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cyclooxygenase-2 in tumor progression and immune regulation in lung cancer.
    Patel S; Chiplunkar S
    Indian J Biochem Biophys; 2007 Dec; 44(6):419-28. PubMed ID: 18320840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
    Pruthi RS; Derksen E; Gaston K
    J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of COX-2 selective inhibitors for prevention and treatment of cancer.
    Amir M; Agarwal HK
    Pharmazie; 2005 Aug; 60(8):563-70. PubMed ID: 16124396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention.
    Dannenberg AJ; Lippman SM; Mann JR; Subbaramaiah K; DuBois RN
    J Clin Oncol; 2005 Jan; 23(2):254-66. PubMed ID: 15637389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
    Koga H
    Cancer; 2003 Aug; 98(4):661-7. PubMed ID: 12910508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
    Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
    Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclooxygenase 2 inhibitors and colorectal cancer].
    Bernardeau-Mozer M; Chaussade S
    Bull Cancer; 2004 May; 91 Spec No():S89-98. PubMed ID: 15239336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?
    Sanborn R; Blanke CD
    Semin Oncol; 2005 Feb; 32(1):69-75. PubMed ID: 15726508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclooxygenase 2 inhibitors and lung carcinoma].
    Spano JP; Chouahnia K; Morère JF
    Bull Cancer; 2004 May; 91 Spec No():S109-12. PubMed ID: 15239338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [COX and study of cancer therapy].
    Yamada N; Ohira M; Hirakawa K
    Gan To Kagaku Ryoho; 2004 Aug; 31(8):1147-51. PubMed ID: 15332534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2 inhibition as a tool to treat and prevent colorectal cancer.
    Tuynman JB; Peppelenbosch MP; Richel DJ
    Crit Rev Oncol Hematol; 2004 Nov; 52(2):81-101. PubMed ID: 15501074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor.
    Hasegawa K; Ohashi Y; Ishikawa K; Yasue A; Kato R; Achiwa Y; Nishio E; Udagawa Y
    Int J Oncol; 2005 May; 26(5):1419-28. PubMed ID: 15809736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.
    Cao Y; Prescott SM
    J Cell Physiol; 2002 Mar; 190(3):279-86. PubMed ID: 11857443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.